title: Staphylococcus aureus-Associated Skin and Soft Tissue Infections: Anatomical Localization, Epidemiology, Therapy and Potential Prophylaxis.
abstract: Skin and soft tissue infections (SSTIs) are among the most common infections worldwide. They range in severity from minor, self-limiting, superficial infections to life-threatening diseases requiring all the resources of modern medicine. Community (CA) and healthcare (HA) acquired SSTIs are most commonly caused by Staphylococcus aureus . They have variable presentations ranging from impetigo and folliculitis to surgical site infections (SSIs). Superficial SSTIs may lead to even more invasive infections such as bacteraemia and osteomyelitis. Here we describe the anatomical localization of the different SSTI associated with S. aureus, the virulence factors known to play a role in these infections, and their current epidemiology. Current prevention and treatment strategies are also discussed. Global epidemiological data show increasing incidence and severity of SSTIs in association with methicillin-resistant S. aureus strains (MRSA). CA-SSTIs are usually less morbid compared to other invasive infections caused by S. aureus, but they have become the most prevalent, requiring a great number of medical interventions, extensive antibiotic use, and therefore a high cost burden. Recurrence of SSTIs is common after initial successful treatment, and decolonization strategies have not been effective in reducing recurrence. Furthermore, decolonization approaches may be contributing to the selection and maintenance of multi-drug resistant strains. Clinical studies from the early 1900s and novel autovaccination approaches suggest an alternative strategy with potential effectiveness: using vaccines to control S. aureus cutaneous infections.
authors.affiliation: GSK Vaccines, Research Center, Via Fiorentina 1, 53100, Siena, Italy.
authors.forename: Reuben
authors.initials: R
authors.lastname: Olaniyi
authors.affiliation: GSK Vaccines, Research Center, Via Fiorentina 1, 53100, Siena, Italy.
authors.forename: Clarissa
authors.initials: C
authors.lastname: Pozzi
authors.affiliation: Division of Plastic and Reconstructive Surgery, University of Siena, Siena, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Grimaldi
authors.affiliation: GSK Vaccines, Research Center, Via Fiorentina 1, 53100, Siena, Italy. fabio.x.bagnoli@gsk.com.
authors.forename: Fabio
authors.initials: F
authors.lastname: Bagnoli
mesh_terms: D000900:Anti-Bacterial Agents; D017714:Community-Acquired Infections; D006801:Humans; D018461:Soft Tissue Infections / Q000453:epidemiology / Q000628:therapy; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000628:therapy; D013207:Staphylococcal Skin Infections; D013211:Staphylococcus aureus
chemical_list: D000900:Anti-Bacterial Agents